Pharma Injecting Life into Digital Health Amidst Funding Downturn
MedCity News
JUNE 16, 2023
The earliest higher-profile digital therapeutic leaders focused on mental and behavioral health with some earning Food and Drug Administration approval for managing conditions such as attention-deficit and hyperactivity disorder, substance-use disorder, and insomnia using a prescription-level app alone or in conjunction with pharmacologic therapy.
Let's personalize your content